Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMOHK1E)

Drug Name

Docosanol Drug Info

Synonyms

Abreva; Debat; Doconsanol; Erazaban; Healip; Herepair; Lidakol; Lidavol; Tadenan; Behenic alcohol; Behenyl alcohol; Docosanol [USAN]; Docosyl alcohol; IK 2; Lanette 22; NAA 422; Stenol 1822; Stenol 1822A; Abreva (TN); Docosanol (USAN); Docosanol (VAN); Erazaban (TN); IK.2; N-Docosanol; Nacol 22-97; V-1326;BEHENYL ALCOHOL, 98%; Docosan-1-ol; Behenyl alcohol, Abreva, 1-Docosanol, Docosanol; Behenyl alcohol, AI3-36489, Behenic alcohol, 1-Docosanol, Docosyl alcohol, IK-2, Tadenan; 1-DOCOSANOL

Indication

Disease Entry	ICD 11	Status	REF
Herpes simplex virus infection	1F00	Approved	[1]

Therapeutic Class

Antiviral Agents

Cross-matching ID

PubChem CID: 12620
ChEBI ID: CHEBI:31000
CAS Number: CAS 661-19-8
TTD Drug ID: DMOHK1E

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Epstein-Barr virus Envelope glycoprotein gp340 (EBV BLLF1)	TT1JL7D	VGP3_EBVP3	Modulator	[2]

------------------------------------------------------------------------------------

References

1	FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 020941.
2	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.